✦ LIBER ✦

Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Chinese patients

✍ Scribed by J. M. Li; L. Wang; Y. Shen; Z. G. Xia; Y. Chen; Q. S. Chen; Y. Chen; X. Y. Zeng; J. H. You; Y. Qian; Z. X. Shen

Publisher: Springer
Year: 2007
Tongue: English
Weight: 161 KB
Volume: 86
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-007-0320-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Irinotecan plus cisplatin and dexamethas

Irinotecan plus cisplatin and dexamethasone (ICD) combination chemotherapy for patients with diffuse large B-cell lymphoma previously treated with Rituximab plus CHOP

✍ Hye Jin Kang; Won Seog Kim; Cheolwon Suh; Yeon Hee Park; Bong Seog Kim; Young Ji 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 242 KB

Rituximab CHOP for successful management

Rituximab CHOP for successful management of diffuse large B-cell lymphoma of the ovary

✍ Nawal Ahbeddou; Mohamed Fetohi; Basma El Khanoussi; Hassan Errihani 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 164 KB

The prognostic value of immunohistochemi

The prognostic value of immunohistochemical subtyping in Chinese patients with de novo diffuse large B-cell lymphoma undergoing CHOP or R-CHOP treatment

✍ Zu-Guang Xia; Zi-Zhen Xu; Wei-Li Zhao; Shu-Qing Zhao; Fei Ding; Yu Chen; Qiu-She 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 129 KB

Successful rituximab-CHOP treatment of s

Successful rituximab-CHOP treatment of systemic lupus erythematosus associated with diffuse large B-cell non-Hodgkin lymphoma

✍ Zs. Simon; T. Tarr; Zs. Ress; L. Gergely; E. Kiss; A. Illes 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 271 KB

Importance of maintaining the relative d

Importance of maintaining the relative dose intensity of CHOP-like regimens combined with rituximab in patients with diffuse large B-cell lymphoma

✍ Tsuneaki Hirakawa; Hiroki Yamaguchi; Norio Yokose; Seiji Gomi; Koiti Inokuchi; K 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 166 KB

Combination of rituximab with chemothera

Combination of rituximab with chemotherapy in diffuse large B-cell lymphoma. Evaluation in daily practice before and after approval of rituximab in this indication

✍ Hervé Ghesquières; Céline Ferlay; Catherine Sebban; Catherine Chassagne; Liana C 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 1 views

## Abstract Randomized trials have demonstrated improved outcome from adding rituximab to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) for patients with diffuse large B‐cell lymphoma (DLBCL). This retrospective study compared the outcomes of 224 patients with DLBCL treated in our i